EP2694072
Samsetning af AKT hemilefnasambandi og abírateróni til notkunar í læknismeðferðir
Status:
EP einkaleyfi: Endurútgefin þýðing EP einkaleyfisEP appl. date:
30.3.2012EP published:
29.11.2017EP application number:
12764765.9
EP translation filed:
14.2.2018Grant published:
15.3.2018EPO information:
European Patent Register
Max expiry date:
29.3.2032Expiry date:
29.3.2027Next due date:
31.3.2027
Title:
COMBINATION OF AKT INHIBITOR COMPOUND AND ABIRATERONE FOR USE IN THERAPEUTIC TREATMENTS
Timeline
Today
30.3.2012EP application
29.11.2017EP Publication
14.2.2018Translation submitted
15.3.2018Registration published
29.3.2027Expires
Owner
Name:
Genentech, Inc.Address:
1 DNA Way, 94080-4990, South San Francisco, CA, US
Inventor
Name:
NANNINI, MichelleAddress:
South San FranciscoCalifornia, US
Name:
SAMPATH, DeepakAddress:
South San FranciscoCalifornia, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201161470803 PDate:
1.4.2011Country:
US
Number:
201161470624 PDate:
1.4.2011Country:
US
Classification
Categories:
A61K 31/517, C07D 239/70, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 28.2.2018
Expires: 29.3.2019
Payer: Árnason Faktor
Number: 8
Paid: 7.2.2019
Expires: 29.3.2020
Payer: Árnason Faktor
Number: 9
Paid: 14.2.2020
Expires: 29.3.2021
Payer: Örn Þór slf.
Number: 10
Paid: 10.2.2021
Expires: 29.3.2022
Payer: Örn Þór slf.
Number: 11
Paid: 15.2.2022
Expires: 29.3.2023
Payer: Árnason Faktor ehf.
Number: 12
Paid: 12.2.2023
Expires: 29.3.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 6.3.2024
Expires: 29.3.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 12.3.2025
Expires: 29.3.2026
Payer: Árnason Faktor ehf.
Number: 15
Paid: 20.3.2026
Expires: 29.3.2027
Payer: Árnason Faktor ehf.